Speakers:
Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM
Linda Toresson, DVM, PhD, Swedish Specialist in Small Animal Internal Medicine
Sara Belchik, MS, PhD candidate
Patrick Barko, DVM, MS, PhD, DACVIM (SAIM)
Jennifer Reinhart, DVM, PhD, DACVIM (SAIM), DACVCP
Event date: 6–7 November 2024 Virtual Event
Ms. Belchik and Drs. Toresson, Barko, and Reinhart join Dr. Suchodolski for a question-and-answer session following their presentations. The discussion covers metronidazole discontinuation, fiber and its influence on the pharmacomicrobiome, strategies to help recovery of bile acid conversion, and more.
Related Content
Switching From Antibiotics to Microbiota-Friendly Treatment in Chronic Diarrhea Dogs - A Case-Based Presentation
Learn how microbiome-centric strategies, such as diet, FMT, prebiotics, and probiotics, can be used to improve management of dogs with chronic GI conditions through a guided review of four relevant clinical cases.
Research Report: Impact of Metronidazole in Adult Cats and the Effects of Antibiotic-Induced Dysbiosis on Fiber Fermentation
Antibiotics are known to negatively affect feline stool quality and gut microbiota. Could a therapeutic diet formulated with increased prebiotic fiber help the microbiome recover after antibiotic administration?
Microbiome Shifts in Canine and Feline Health and Disease
Shifts in gut microbiota taxa and/or diversity can result in functional changes in the microbiome. Learn why early recognition of microbiome shifts may improve management of patients with GI conditions.
Dietary Tryptophan and the Gut Microbiome: Emerging Approaches to Optimize Intestinal and Systemic Health
Learn how tryptophan that is not used for protein synthesis can be metabolized into protective and/or toxic compounds. Therapeutic interventions that target tryptophan metabolism are promising, but more research is needed.
How the Microbiome Alters Drug Metabolism
Many drugs affect the gut microbiome, but how does the gut microbiome influence orally administered medications? Learn about the emerging field of pharmacomicrobiomics.